Gmed stock price forecast chart patterns show GMED forming a

Chart patterns show GMED forming a bullish rectangle, with traders anticipating a breakout upon earnings report release. The GMED stock price forecast suggests strong probability of hitting $67 in that technical scenario. Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have forecasts for Globus Medical going out to 2027, and you can see them free on our platform here. Meanwhile, da Vinci 5, which is the company’s next-generation multiport robotic system, received FDA 510(k) clearance in March of this year. Da Vinci 5 is engineered to enhance accuracy and precision through its next-generation 3D display and imaging systems. During the earnings call, management noted that surgeon feedback on da Vinci 5 emphasized improvements in precision, imaging, and ergonomics. The company installed 110 da Vinci 5 systems in Q3, with more than 12,000 procedures completed in about six months. Institutional inflows have strengthened support levels in the $60–$62 range, pointing to resilience against broader healthcare sector volatility.